No added diagnostic value of non-phosphorylated tau fraction (p-tau(rel)) in CSF as a biomarker for differential dementia diagnosis

BACKGROUND: The Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarkers Aβ(1–42), t-tau, and p-tau(181) overlap with other diseases. New tau modifications or epitopes, such as the non-phosphorylated tau fraction (p-tau(rel)), may improve differential dementia diagnosis. The goal of this study...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Alzheimers Res Ther
Glavni autori: Goossens, Joery, Bjerke, Maria, Struyfs, Hanne, Niemantsverdriet, Ellis, Somers, Charisse, Van den Bossche, Tobi, Van Mossevelde, Sara, De Vil, Bart, Sieben, Anne, Martin, Jean-Jacques, Cras, Patrick, Goeman, Johan, De Deyn, Peter Paul, Van Broeckhoven, Christine, van der Zee, Julie, Engelborghs, Sebastiaan
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5513364/
https://ncbi.nlm.nih.gov/pubmed/28709448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0275-5
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items